![Michael Steiner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Michael Steiner has a current job as a Member-Supervisory Board at Bitop AG.
Actieve functies van Michael Steiner
Bedrijven | Functie | Begin |
---|---|---|
Bitop AG
![]() Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Bitop AG
![]() Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Consumer Non-Durables |